# EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety

> **NCT01834768** · PHASE2 · UNKNOWN · sponsor: **CHU de Reims** · enrollment: 31 (estimated)

## Conditions studied

- Chronic Kidney Insufficiency
- Kidney Transplantation

## Interventions

- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT01834768
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-12
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834768, "EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01834768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*